SCHEMBL2798339

SCHEMBL2798339

CCOC(=O)/C(C#N)=C1/CCCCC1C(=O)O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.44
KDM4E B2RXH2 4/20 0.44
KMT2A Q03164 4/20 0.44
MEN1 O00255 3/20 0.44
ALDH1A1 P00352 9/20 0.43
SMN1; SMN2 Q16637 3/20 0.43
HPGD P15428 3/20 0.42
L3MBTL1 Q9Y468 3/20 0.40
NPSR1 Q6W5P4 1/20 0.40
RAB9A P51151 4/20 0.38
HSD17B10 Q99714 2/20 0.38
TSHR P16473 1/20 0.37
CYP2D6 P10635 1/20 0.36
NPC1 O15118 2/20 0.36
MAPK1 P28482 3/20 0.35
CASP3 P42574 1/20 0.34
SENP8 Q96LD8 1/20 0.34
SENP7 Q9BQF6 1/20 0.34
SENP6 Q9GZR1 1/20 0.34
TDP1 Q9NUW8 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2798343 1.00 MAPT (0.44) MAPTKDM4EKMT2AMEN1ALDH1A1
SCHEMBL13086584 0.89 MAPT (0.44) MAPTKDM4EKMT2AMEN1ALDH1A1
SCHEMBL7904295 0.89 MAPT (0.44) MAPTKDM4EKMT2AMEN1ALDH1A1
SCHEMBL13265541 0.86 KDM4E (0.42) MAPTKDM4EKMT2AMEN1ALDH1A1
SCHEMBL6381203 0.83 MAPT (0.47) MAPTKDM4EKMT2AMEN1ALDH1A1
SCHEMBL6381199 0.83 MAPT (0.47) MAPTKDM4EKMT2AMEN1ALDH1A1
SCHEMBL13155068 0.82 ALDH1A1 (0.44) MAPTKDM4EKMT2AMEN1ALDH1A1
SCHEMBL19382162 0.79 MAPT (0.48) MAPTKDM4EKMT2AMEN1ALDH1A1
SCHEMBL21247132 0.79 KMT2A (0.48) MAPTKDM4EKMT2AMEN1ALDH1A1
SCHEMBL21247133 0.79 KMT2A (0.48) MAPTKDM4EKMT2AMEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100261706-A1 SUBSTITUTED TETRACYCLIC 1H-INDENO [1,2-B]PYRIDINE-2(5H)-ONE ANALOGS THEREOF AND USES THEREOF INOTEK PHARMACEUTICALS CORPORATION (US) 2010-10-14 US disclosed
WO-2010077663-A2 SUBSTITUTED TETRACYCLIC 1H-INDENO (1,2-B) PYRIDINE-2 (5H)-ONE ANALOGS THEREOF AND USES THEREOF INOTEK PHARMACEUTICALS CORPORATION (US) 2010-07-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100261706-A1 SUBSTITUTED TETRACYCLIC 1H-INDENO [1,2-B]PYRIDINE-2(5H)-ONE ANALOGS THEREOF AND USES THEREOF TNNI3, TNNT2, ALDH1A2 MAPT 555/4885KDM4E 3177/4885KMT2A 4334/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.